Screener
Monte Rosa Therapeutics, Inc. GLUE Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.
The source filing: Monte Rosa Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:09 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336711
The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use, or ROU, assets and operating lease liabilities in the condensed consolidated balance sheets. The Company has no finance leases as of June 30, 2026.
Item 1. Financial Statements
FAQ
- What is Monte Rosa Therapeutics, Inc.'s finance lease liabilities?
- Monte Rosa Therapeutics, Inc. (GLUE) reported finance lease liabilities of $0 in Q2 2026.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.
Ask your AI about Monte Rosa Therapeutics, Inc.'s finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude